Gå direkt till huvudinnehållet

Trombofili

Senast uppdaterad: Publicerad:
Sakkunnig:

  1. Rosendaal FR. Venous thrombosis: a multicausal disease. The Lancet 1999; 353: 1167-73. The Lancet  
  2. Federman DG, Kirsner RS. Rewiew article: An update on hypercoagulable disorders. Arch Intern Med 2001; 161: 1051-1056. PubMed  
  3. Bucciarelli P, Rosendaal FR, Tripodi A, et al: Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study. Arterioscler Thromb Vasc Biol 1999 Apr; 19(4): 1026-33. PubMed  
  4. Lane DA, Mannucci PM, Bauer KA, et al: Inherited thrombophilia: Part 1. Thromb Haemost 1996 Nov; 76(5): 651-62. PubMed  
  5. Rosing J, Middeldorp S, Curvers J, Christella M et al. Low-dose oral contraceptives and aquired resistance to activated protein C: a randomised cross-over study. The Lancet 1999; 354: 2036-40. The Lancet  
  6. Meijers JCM, Tekelenburg WLH, Bouma BN, Bertina RM, Rosendal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med. 2000; 342: 696-701. PubMed  
  7. Levine JS, Branch DW, Rauch J: The antiphospholipid syndrome. N Engl J Med 2002 Mar 7; 346(10): 752-63. PubMed  
  8. Myones BL, McCurdy D: The antiphospholipid syndrome: immunologic and clinical aspects. Clinical spectrum and treatment. J Rheumatol 2000 Apr; 27 Suppl 58: 20-8.
  9. Wilson WA: Classification criteria for antiphospholipid syndrome. Rheum Dis Clin North Am 2001 Aug; 27(3): 499-505. PubMed  
  10. Greaves M. Antiphospholipid antibodies and thrombosis. The Lancet 1999; 353: 1348-53. The Lancet  
  11. Heegaard NHH, Locht H. Immunbetinget trombofili. Ugeskr Læger 2005; 167: 2861-4. PubMed  
  12. Rai R, Cohen H, Dave Med, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314: 253-57. British Medical Journal  
  13. Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 2005; 293: 2352-61. Journal of the American Medical Association  
  14. Lidegaard Ø, Nielsen LH, Skovlund CW, et al. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. BMJ 2011; 343: d6423. BMJ (DOI)  
  • Honar Cherif, med dr och överläkare, Hematologikliniken, Akademiska sjukhuset, Uppsala

Tidigare sakkunniga

  • Bjørnar Grenne, läkare i specialisering och PhD, Sørlandet Sykehus Arendal
  • Odd Kildahl-Andersen, överläkare, medicinläkare, medicinavdelningen, Universitetssykehuset Nord-Norge, Harstad sykehus